Skip Header

Contribute Send feedback
Read comments (?) or add your own

Q9NWQ8 (PAG1_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 75. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (2) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1
Alternative name(s):
Csk-binding protein
Transmembrane adapter protein PAG
Transmembrane phosphoprotein Cbp
Gene names
Name:PAG1
Synonyms:CBP, PAG
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length432 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and FCER1 (high affinity immunoglobulin epsilon receptor)-mediated signaling in mast cells. Promotes CSK activation and recruitment to lipid rafts, which results in LCK inhibition. Inhibits immunological synapse formation by preventing dynamic arrangement of lipid raft proteins. May be involved in cell adhesion signaling. Ref.1

Subunit structure

Interacts with FYN. When phosphorylated, interacts with CSK. Interacts with SLC9A3R1/EBP50. In resting T-cells, part of a PAG1-SLC9A3R1-MSN complex which is disrupted upon TCR activation. Interacts with LYN on plasma membrane lipid rafts. Identified in a complex with LYN and STAT3. Ref.1 Ref.5 Ref.9

Subcellular location

Cell membrane; Single-pass type III membrane protein. Note: Present in lipid rafts. Ref.1 Ref.9

Tissue specificity

Ubiquitously expressed. Present in germinal center B-cells, plasma cells, T-cells, monocytes and platelets (at protein level). Ref.1 Ref.6

Post-translational modification

Palmitoylated. Ref.1

Phosphorylated by FYN on Tyr-317 in resting T-cells; which promotes interaction with CSK. Dephosphorylated by PTPRC/CD45 upon TCR activation; which leads to CSK dissociation. May also be dephosphorylated by PTPN11. Hyperphosphorylated in mast cells upon FCER1 activation. Phosphorylated by LYN. Ref.1 Ref.7 Ref.8 Ref.9 Ref.10 Ref.11

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 432432Phosphoprotein associated with glycosphingolipid-enriched microdomains 1
PRO_0000083338

Regions

Topological domain1 – 1616Extracellular Potential
Transmembrane17 – 3721Helical; Signal-anchor for type III membrane protein; Potential
Topological domain38 – 432395Cytoplasmic Potential
Region317 – 3204Interaction with CSK
Region430 – 4323Interaction with SLC9A3R1

Amino acid modifications

Modified residue1631Phosphotyrosine Ref.11
Modified residue1811Phosphotyrosine By similarity
Modified residue2271Phosphotyrosine Ref.10 Ref.11
Modified residue3171Phosphotyrosine; by FYN and LYN Ref.1 Ref.7 Ref.9 Ref.11
Modified residue3411Phosphotyrosine Ref.7 Ref.10
Modified residue3591Phosphotyrosine Ref.7 Ref.11
Modified residue3801Phosphoserine By similarity
Modified residue3871Phosphotyrosine Ref.11
Modified residue4171Phosphotyrosine Ref.7 Ref.8 Ref.11
Lipidation371S-palmitoyl cysteine Probable
Lipidation401S-palmitoyl cysteine Probable

Experimental info

Mutagenesis1051Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis1631Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis1811Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis2271Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis2991Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis3171Y → F: No effect on interaction with FYN. Abolishes interaction with CSK. Ref.1
Mutagenesis3411Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis3591Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis3871Y → F: No effect on interaction with FYN or CSK. Ref.1
Mutagenesis4171Y → F: No effect on interaction with FYN or CSK. Ref.1
Sequence conflict41A → V in AAH90931. Ref.4
Sequence conflict361L → P in BAA91321. Ref.2

Sequences

Sequence LengthMass (Da)Tools
Q9NWQ8 [UniParc].

Last modified December 20, 2005. Version 2.
Checksum: E86272A0B7E3328C

FASTA43246,981
        10         20         30         40         50         60 
MGPAGSLLGS GQMQITLWGS LAAVAIFFVI TFLIFLCSSC DREKKPRQHS GDHENLMNVP 

        70         80         90        100        110        120 
SDKEMFSRSV TSLATDAPAS SEQNGALTNG DILSEDSTLT CMQHYEEVQT SASDLLDSQD 

       130        140        150        160        170        180 
STGKPKCHQS RELPRIPPES AVDTMLTARS VDGDQGLGME GPYEVLKDSS SQENMVEDCL 

       190        200        210        220        230        240 
YETVKEIKEV AAAAHLEKGH SGKAKSTSAS KELPGPQTEG KAEFAEYASV DRNKKCRQSV 

       250        260        270        280        290        300 
NVESILGNSC DPEEEAPPPV PVKLLDENEN LQEKEGGEAE ESATDTTSET NKRFSSLSYK 

       310        320        330        340        350        360 
SREEDPTLTE EEISAMYSSV NKPGQLVNKS GQSLTVPEST YTSIQGDPQR SPSSCNDLYA 

       370        380        390        400        410        420 
TVKDFEKTPN STLPPAGRPS EEPEPDYEAI QTLNREEEKA TLGTNGHHGL VPKENDYESI 

       430 
SDLQQGRDIT RL 

« Hide

References

« Hide 'large scale' references
[1]"Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation."
Brdicka T., Pavlistova D., Bruyns E., Leo A., Korinek V., Angelisova P., Scherer J., Shevchenko A., Shevchenko A., Hilgert I., Cerny J., Drbal K., Kuramitsu Y., Horejsi V., Schraven B.
J. Exp. Med. 191:1591-1604(2000) [PubMed: 10790433] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 264-274, IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT TYR-317, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PALMITOYLATION AT CYS-37 AND CYS-40, MUTAGENESIS OF TYR-105; TYR-163; TYR-181; TYR-227; TYR-299; TYR-317; TYR-341; TYR-359; TYR-387 AND TYR-417, INTERACTION WITH FYN AND CSK, FUNCTION.
[2]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Brain and Ileal mucosa.
[3]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[4]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Brain and Lymph.
[5]"Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton."
Brdickova N., Brdicka T., Andera L., Spicka J., Angelisova P., Milgram S.L., Horejsi V.
FEBS Lett. 507:133-136(2001) [PubMed: 11684085] [Abstract]
Cited for: INTERACTION WITH SLC9A3R1.
[6]"Transmembrane adaptor molecules: a new category of lymphoid-cell markers."
Tedoldi S., Paterson J.C., Hansmann M.-L., Natkunam Y., Rudiger T., Angelisova P., Du M.Q., Roberton H., Roncador G., Sanchez L., Pozzobon M., Masir N., Barry R., Pileri S., Mason D.Y., Marafioti T., Horejsi V.
Blood 107:213-221(2006) [PubMed: 16160011] [Abstract]
Cited for: TISSUE SPECIFICITY.
[7]"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer."
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. expand/collapse author list , Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.
Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-317; TYR-341; TYR-359 AND TYR-417, MASS SPECTROMETRY.
Tissue: Lung carcinoma.
[8]"Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks."
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007) [PubMed: 17389395] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-417, MASS SPECTROMETRY.
Tissue: Mammary epithelium.
[9]"Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts."
Tauzin S., Ding H., Khatib K., Ahmad I., Burdevet D., van Echten-Deckert G., Lindquist J.A., Schraven B., Din N.U., Borisch B., Hoessli D.C.
Blood 111:2310-2320(2008) [PubMed: 18070987] [Abstract]
Cited for: PHOSPHORYLATION AT TYR-317, INTERACTION WITH LYN AND STAT3, SUBCELLULAR LOCATION.
[10]"Large-scale proteomics analysis of the human kinome."
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H.
Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-227 AND TYR-341, MASS SPECTROMETRY.
[11]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-163; TYR-227; TYR-317; TYR-359; TYR-387 AND TYR-417, MASS SPECTROMETRY.
Tissue: Leukemic T-cell.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AF240634 mRNA. Translation: AAF67343.1.
AK000680 mRNA. Translation: BAA91321.1.
AK289818 mRNA. Translation: BAF82507.1.
CH471068 Genomic DNA. Translation: EAW87086.1.
BC090931 mRNA. Translation: AAH90931.1.
BC112159 mRNA. Translation: AAI12160.1.
IPIIPI00020464.
RefSeqNP_060910.3. NM_018440.3.
UniGeneHs.266175.

3D structure databases

ProteinModelPortalQ9NWQ8.
ModBaseSearch...

Protein-protein interaction databases

IntActQ9NWQ8. 1 interaction.
MINTMINT-220429.
STRINGQ9NWQ8.

PTM databases

PhosphoSiteQ9NWQ8.

Polymorphism databases

DMDM84029384.

Proteomic databases

PeptideAtlasQ9NWQ8.
PRIDEQ9NWQ8.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000220597; ENSP00000220597; ENSG00000076641.
GeneID55824.
KEGGhsa:55824.
UCSCuc003ybz.1. human.

Organism-specific databases

CTD55824.
GeneCardsGC08M081880.
H-InvDBHIX0007615.
HGNCHGNC:30043. PAG1.
HPAHPA001632.
MIM605767. gene.
neXtProtNX_Q9NWQ8.
PharmGKBPA142671201.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG11418.
GeneTreeENSGT00390000002061.
HOGENOMHBG279366.
HOVERGENHBG055052.
InParanoidQ9NWQ8.
OMAVNKPGQS.
OrthoDBEOG4CRM0T.
PhylomeDBQ9NWQ8.

Enzyme and pathway databases

Pathway_Interaction_DBbcr_5pathway. BCR signaling pathway.
tcrpathway. TCR signaling in naive CD4+ T cells.
cd8tcrpathway. TCR signaling in naive CD8+ T cells.
ReactomeREACT_111102. Signal Transduction.
REACT_6900. Immune System.

Gene expression databases

ArrayExpressQ9NWQ8.
BgeeQ9NWQ8.
CleanExHS_PAG1.
GenevestigatorQ9NWQ8.
GermOnlineENSG00000076641. Homo sapiens.

Family and domain databases

ProtoNetSearch...

Other

NextBio61018.
SOURCESearch...

Entry information

Entry namePAG1_HUMAN
AccessionPrimary (citable) accession number: Q9NWQ8
Secondary accession number(s): A8K1A3 expand/collapse secondary AC list , Q2M1Z9, Q5BKU4, Q9NYK0
Entry history
Integrated into UniProtKB/Swiss-Prot: December 20, 2005
Last sequence update: December 20, 2005
Last modified: January 25, 2012
This is version 75 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 8

Human chromosome 8: entries, gene names and cross-references to MIM

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot